Journal Mobile Options
Table of Contents
Vol. 41, No. 2, 1999
Issue release date: February 1999
Eur Neurol 1999;41:88–93
(DOI:10.1159/000008009)

Lysine-Acetylsalicylic Acid in Acute Migraine Attacks

Limmroth V. · May A. · Diener H.-C.
Neurologische Universitätsklinik Essen, Germany

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Vasoconstrictive agents have been widely used in the treatment of migraine. These types of drugs have various side effects and are not suitable for many patients. Due to nausea or vomiting, nonoral treatment is often required, but only a few nonvasoconstrictive drugs exist in a parenteral form and are suitable for the treatment of acute migraine in the emergency setting. In a randomized, double-blind, crossover trial we evaluated the efficacy of 1,000 mg lysine-acetylsalicylic acid i.v. (LAS) compared to 0.5 mg ergotamine s.c. in 56 patients (112 attacks) with acute migraine. To gain further insight into the possible role of vasoconstriction, blood flow velocities (BFV) were measured in intra- and extracranial arteries using duplex sonography and transcranial Doppler sonography. Both agents were equally potent in relieving headache. Intravenous LAS resulted in a significantly faster relief and had fewer side effects. LAS had no effect on BFV. Ergotamine increased BFV in the middle cerebral artery only. No correlation was found between changes in BFV and the relief of headache. This is the first trial to compare the intravenous formulation of LAS in the treatment of migraine with another antimigraine medication and suggests that it is an effective and safe drug for the parenteral treatment of acute migraine attacks.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Tammisto T, Tigerstedt I, Kortilla K: Comparison of lysine acetylsalicylic acid and oxycodone in postoperative pain following upper abdominal surgery. Ann Chir Gynaecol 1980;69:287–292.

    External Resources

  2. McAteer E, Dundee JW: Injectable aspirin as a post-operative analgesic. Br J Anaesth 1981;53:1069–1071.

    External Resources

  3. Jones RM, Cashman JN, Foster JM, Wedley JMG, Adams AP: Comparison of infusions of morphine and lysine acetylsalicylate for the relief of pain following thoracic surgery. Br J Anaesth 1985;57:259–263.

    External Resources

  4. Taneri Z, Petersen-Braun M: Therapie des akuten Migräneanfalls mit intravenös applizierter Acetylsalicylsäure: eine placebokontrollierte Doppelblindstudie. Schmerz 1995;9:124–129.
  5. Headache Classification Committee of the International Headache Society: Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8(suppl 7):1–96.
  6. The Subcutaneous Sumatriptan International Study Group: Treatment of migraine attacks with sumatriptan. N Engl J Med 1991;325:316–321.
  7. Tfelt-Hansen P, Henry P, Mulder LJ, Scheidewaert RG, Schoenen J, Chazot G: The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine. Lancet 1995;346:923–926.
  8. Friberg L, Oleson J, Iversen HK, Sperling B: Migraine pain associated with middle cerebral artery dilatation: Reversal by sumatriptan. Lancet 1991;338:13–17.
  9. Caekebeke JFV, Ferrari MD, Zwetsloot CP, Jansen J, Saxena PR: Antimigraine drug sumatriptan increased blood flow velocity in large cerebral arteries during migraine attacks. Neurology 1992;42:1522–1526.
  10. Zwetsloot CT, Caekebeke CVJ, Jansen JC, Odink J, Ferrari MD: Blood flow velocity changes in migraine attacks – A transcranial Doppler study. Cephalalgia 1991;11:103–107.
  11. Diener HC, Peters C, Rudzio M, Noe A, Dichgans J, Ehrmann R, Tfelt-Hansen P: Ergotamine, flunarizine and sumatriptan do not change cerebral blood flow velocity in normal subjects and migraneurs. J Neurol 1991;238:245–250.
  12. Limmroth V, May A, Auerbach P, Wosnitza G, Eppe T, Diener HC: Changes of cerebral blood flow velocity after treatment with sumatriptan or placebo and its implication in the pathophysiology of migraine. J Neurol Sci 1996;138:60–65.

    External Resources

  13. Buzzi MG, Sakas DE, Moskowitz MA: Indomethacin and acetylsalicylic acid block neurogenic plasma protein extravasation in rat dura mater. Eur J Pharmacol 1989;165:251–258.
  14. Kaube H, Hoskin KL, Goadsby PJ: Acetylsalicylic acid inhibits cerebral cortical vasodilatation caused by superior sagittal sinus stimulation in the cat. Eur J Neurol 1994;1:141–146.
  15. Goadsby PJ, Hoskin KL, Kaube H: Autoradiographic evaluation of acetylsalicylic acid distribution in the brain-stem of the cat; in Rose FC (ed): New Advances in Headache Research. London, Smith-Gordon, 1994, vol 4, pp 151–153.
  16. Kaube H, Hoskin KL, Goadsby PJ: Sumatriptan inhibits central trigeminal neurons only after blood-brain barrier disruption. Br J Pharmacol 1993;109:788–792.
  17. Kwon G, Hill JR, Corbett JA, McDaniel ML: Effects of aspirin on nitric oxide formation and de novo protein synthesis by RINm5F cells and rat islets. Mol Pharmacol 1997;52:398–405.

    External Resources



Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50